FCVB:Save the Eyeball,Avoid Removal
  • About Us
    • Profile
    • Culture
    • Development
    • R&D Achievements
      • Paper
      • Foundation
      • Patent
  • Products
    • FCVB
      • Introduction
      • Developing
      • Video
      • Clinical list
      • FAQ
    • FCB
    • HM
  • News
    • Company News
    • Products News
    • Media News
  • Partner
    • Clinical Hospital
    • National Distributor
    • International Distributor
  • Patients Center
    • Case
    • Surgery Cost
  • Recruitment
  • Contact Us
  • 中文
  • Search
  • Menu

Developing

2019.12.12

FCVB clinical trial 10th anniversary summary meeting

2019.07.02

Professor Gao and Chairman of the International Society of Ocular Trauma Ferenc Kuhn

Carry out clinical application surgery in Poland

2019.05.15

Clinical application surgery in the Netherlands

2019.05.13

Clinical application surgery in the Republic of Latvia

2019.03.03

Vesber Nansha base opened

2019.02.18

Carry out clinical application surgery in Pakistan

2018.12.17

Clinical application of surgery in Russia

2017.08

Obtained CFDA registration certificate

2017

Clinical application in Turkey, Belgium, Greece, United Kingdom

2015

Obtained European CE certificate

2009-2012

Multi-center clinical trials

2009.06

The first clinical trial of FCVB in the world

2008.05

FCVB registration inspection report

2007.10.30

We Founded

2000年

In order to find the structure that can support the retina eyeball for a long time

And residual functional vitreous substitutes,

Our developers put forward the idea of FCVB.

  • Profile
  • Culture
  • Development
  • R&D Achievements
    • Paper
    • Fund
    • Patent

Contact Us

EMAIL: info@vesber.com
TELE: +86-020-2868-7088

Adress

Floor 1-6, Building 11, No. 6 Nanjiang Second Road, Zhujiang Street, Nansha District, Guangzhou

Links:

©版权归广州卫视博生物科技有限公司所属 粤ICP备14063046号-2
Scroll to top